AlemtuzumabA humanized monoclonal antibody directed against CD52
Alemtuzumab is a humanized monoclonal antibody directed against CD52. Alemtuzumab is being used in the treatment of CD52 expressing tumours and relapsing remitting form of multiple sclerosis.
What can Sanquin do for you?
- Measure drug levels of free drug in the serum using an validated ELISA.
- Measure the immunogenicity of alemtuzumab.
- Provide assay reagents or co-develop novel testing strategies.
- Folllowing ISO, FDA/EMA, RUO guidelines.
Enquire about our drug level and ADA assays by emailing us at [email protected].